Fulcrum Therapeutics, Inc.

NASDAQ:FULC

3.64 (USD) • At close November 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -97.335-109.872-80.847-70.819-82.677-32.588-22.964
Depreciation & Amortization 2.1722.4142.5152.3792.0531.3450.715
Deferred Income Tax -20.307001.932000
Stock Based Compensation 14.80213.3511.077.354.2242.1591.371
Change In Working Capital -4.613-3.094-11.8897.50311.3266.5220.804
Accounts Receivables -0.3082.5-0.5-2000
Inventory 001.2460.229000
Accounts Payables -0.853-1.1760.9731.7730.803-0.020.208
Other Working Capital -3.452-4.418-13.6087.50110.5236.5420.596
Other Non Cash Items 14.3160.1520.673-225.5914.8692.593
Operating Cash Flow -90.965-97.05-78.478-53.655-39.483-22.562-20.074
Investing Activities:
Investments In Property Plant And Equipment -0.508-1.963-1.713-1.342-0.853-8.981-1.908
Acquisitions Net 36.184-14.376127.95655.796000
Purchases Of Investments -194.892-151.153-216.234-124.27000
Sales Maturities Of Investments 158.708165.52988.27868.474000
Other Investing Activites -36.18414.376-127.956-55.796-0.09100
Investing Cash Flow -36.69212.413-129.669-57.138-0.944-8.981-1.908
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 118.12280.804182.85769.94664.1730.0120.041
Common Stock Repurchased 000-0.193-0.03400
Dividends Paid 0000000
Other Financing Activities 0.7773.5193.66869.9460.249105.08317.621
Financing Cash Flow 118.12284.323186.50771.13264.343105.02517.662
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -9.535-0.314-21.64-39.66123.91673.482-4.32
Cash At End Of Period 25.56336.1936.50458.14497.80573.8890.407